Features
This information can help clinicians and patients understand the risks and benefits of prostate cancer screening. Provider and patient sheets are included.
Features
Prostate cancer screening is important in the early detection of prostate cancer because many patients do not have symptoms. This guide reviews current screening tests, recommendations, and risk factors.
Uncategorized
The FDA has notified healthcare professionals that the Warnings and Precautions section of the labeling for the class of 5-alpha reductase inhibitors has been revised to include new safety information about the increased risk of being diagnosed with high-grade prostate cancer.
Drug News
Male baldness is associated with prostate cancer, with more severe balding patterns more strongly associated with cancer.
Drug News
The protein SPOP, which is most frequently mutated in human prostate cancers, is a key regulator of androgen receptor activity that prevents uncontrolled growth of cells in the prostate and thus helps prevent cancer.
Drug News
Copy number variation (CNV) in both malignant and benign prostate tissue is predictive of prostate cancer relapse.
Drug News
In men with an initial benign biopsy or transurethral resection of the prostate, obesity is associated with the presence of precancerous lesions in the initial biopsy and a higher risk of developing prostate cancer.
Drug News
Men diagnosed with prostate cancer are more likely to die from other conditions, including heart disease, than from prostate cancer.
Drug News
Circumcision appears to confer a protective effect against the development of prostate cancer.
Drug News
The ChemPro 100-electronic nose can discriminate prostate cancer from benign prostatic hyperplasia using urine headspace.